Pharma Focus Asia
KP - Sustainable Packaging Solutions

Eli Lilly to Invest US$470million for Pharmaceutical Plant Construction


Eli Lilly and Company will invest US$470 million for the construction of a new state-of-the-art pharmaceutical manufacturing facility in North Carolina's Research Triangle Park.


The new manufacturing site will manufacture parenteral/injectable products and delivery devices.

The new facility will allow Eli Lilly to expand its capacity to make the company's medicines that are helping people will serious illnesses and help the company prepare for new medicines coming from its robust pipeline in the future.

The North Carolina General Assembly, the North Carolina Community College System, the North Carolina Biotechnology Center, Durham County, the Greater Durham Chamber of Commerce and Duke Energy have partnered with N.C. Commerce and the Economic Development Partnership of N.C. on this project.


NameEli Lilly and Company 
Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?